Naturmega to Showcase Two Sides of Omega-3 Innovation at SupplySide Global 2026.
NATURMEGA | PRESS RELEASE Naturmega to Showcase Two Sides of Omega-3 Innovation at SupplySide Global 2026 From sourcing flexibility and sensory performance to advanced phospholipid science and molecular design, Naturmega will showcase how Omega-3 innovation can address what brands need today, and what may be possible next. Barranquilla, Colombia — September 2026. Naturmega will return […]
BeyondKrill: What the 2026 GOED Report Confirms About Where Omega-3 Is Headed
Naturmega Insights | Market Intelligence BeyondKrill: What the 2026 GOED Report Confirms About Where Omega-3 Is Headed The data validates the shift we built our strategy around: one company, two innovation engines — Essential Solutions for today, Next-Generation Solutions for what’s next. Naturmega Market Intelligence GOED’s 2026 Global EPA & DHA Omega-3 Ingredient Market Report […]
A New Chapter in Omega-3 Beyond Source
Naturmega | Articles & News A New Chapter in Omega-3: Beyond a Single Source As supply diversification, sustainability and formulation flexibility reshape the category, dual-origin strategies represent the next evolution in omega-3 ingredient design. For decades, the omega-3 industry has advanced through continuous refinement. Higher concentrations improved efficacy. Better purification technologies enhanced quality. New delivery […]
Naturmega & BIOS Foundation Advance New Clinical Study on Phospholipid Omega-3 in Colombia
BIOS Foundation, in collaboration with Naturmega, a Colombian company specialized in advanced lipid science, announced the progress of a new clinical study to evaluate phospholipid omega-3 formulations against conventional omega-3 in patients with mixed dyslipidemia. This research is part of a broader scientific agenda focused on the development and clinical validation of new lipid structures […]
Naturmega Advances Ruby-O® Clinical Program with Newly Registered Trial
Naturmega Advances Ruby-O® Clinical Program with Newly Registered Trial As part of its structured clinical roadmap for Ruby-O®, Naturmega continues to build the scientific foundation behind its next-generation phospholipid omega-3 technology. Following the publication of its first clinical study earlier this year, the company is expanding its research program through new human investigations designed to […]
Naturmega Unveils SupriaX2, A New Alternative to Krill Oil
Naturmega unveils Supria X2™, a new generation of phospholipid omega-3 beyond krill SupriaX2™, a next-generation omega-3 ingredient, introduces a new approach to phospholipid delivery, enabling higher levels of phospholipids bonded to EPA + DHA for improved efficiency, absorption, and performance. Phospholipids have long been recognized for enhancing omega-3 bioavailability, a concept popularized by krill oil. […]
Naturmega Brings the Present and Future of Omega-3 to Vitafoods Europe 2026
Naturmega, an advanced lipid science company, will participate in Vitafoods Europe 2026 with an expanded presence that brings together its full portfolio of omega-3 technologies, from commercially ready solutions to next-generation lipid innovation. Exhibiting alongside its strategic partner De Wit Specialty Oils at Booth #3F146, Naturmega will present a unified vision under its campaign “Beyond […]
The Next Phase of DHA
The Next Phase of DHA: Meeting Modern Expectations with Modern Approaches DHA is one of the most established nutrients in the market, and the category is naturally evolving to meet new expectations. For decades, docosahexaenoic acid (DHA) has been supported by a substantial body of research linking adequate intake with benefits across the human lifespan. […]
Algalis™ Receives Kosher Certification, Strengthening Its Global DHA Platform
Algalis™ Receives Kosher Certification, Strengthening Its Global DHA Platform DHA is one of the most researched and recognized omega-3 fatty acids in human health. From prenatal development and early childhood growth to cognitive performance and healthy aging, DHA plays a foundational role in brain structure, visual function, and cellular membrane […]
Naturmega® Announces Peer-Reviewed Clinical Results for Ruby-O® Balance, Demonstrating Stronger Triglyceride Responder Outcomes with a Lower Omega-3 Dose
Naturmega® Announces Peer-Reviewed Clinical Results for Ruby-O® Balance, Demonstrating Stronger Triglyceride Responder Outcomes with a Lower Omega-3 DosePublished in BMC Complementary Medicine and Therapies, the study validates Ruby-O®’s bonded phospholipid omega-3 platform as a more efficient, cell-oriented approach to omega-3 delivery. Barranquilla, Colombia – [January, 2026] – Naturmega, a pioneer in advanced lipid science, announced […]